One strategy involves culturing CAR-T cells in a medium supplemented with linoleic acid (LA), which shifts CAR-T cell metabolism, reduces exhaustion markers, increases the memory phenotype, and improves the tumor-killing capacity of both mouse CD8 and human CAR-T cells [29]. This evidence concerns the gene CD8A and neoplasm.